Sequence specific peptidomimetic molecules inhibitors of a protein–protein interaction at the helix 1 level of c‐Myc

ABSTRACT Our work is focused in the broad area of strategies and efforts to inhibit protein–protein interactions. The possible strategies in this field are definitely much more varied than in the case of ATP‐pocket inhibitors. In our previous work (10), we reported that a retro‐inverso (RI) form of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The FASEB journal 2005-04, Vol.19 (6), p.1-26
Hauptverfasser: Nieddu, E., Melchiori, A., Pescarolo, M. P., Bagnasco, L., Biasotti, B., Licheri, B., Malacarne, D., Tortolina, L., Castagnino, N., Pasa, S., Cimoli, G., Avignolo, C., Ponassi, R., Balbi, C., Patrone, E., D'Arrigo, C., Barboro, P., Vasile, F., Orecchia, P., Carnemolla, B., Damonte, G., Millo, E., Palomba, D., Fassina, G., Mazzei, M., Parodi, S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 26
container_issue 6
container_start_page 1
container_title The FASEB journal
container_volume 19
creator Nieddu, E.
Melchiori, A.
Pescarolo, M. P.
Bagnasco, L.
Biasotti, B.
Licheri, B.
Malacarne, D.
Tortolina, L.
Castagnino, N.
Pasa, S.
Cimoli, G.
Avignolo, C.
Ponassi, R.
Balbi, C.
Patrone, E.
D'Arrigo, C.
Barboro, P.
Vasile, F.
Orecchia, P.
Carnemolla, B.
Damonte, G.
Millo, E.
Palomba, D.
Fassina, G.
Mazzei, M.
Parodi, S.
description ABSTRACT Our work is focused in the broad area of strategies and efforts to inhibit protein–protein interactions. The possible strategies in this field are definitely much more varied than in the case of ATP‐pocket inhibitors. In our previous work (10), we reported that a retro‐inverso (RI) form of Helix1 (H1) of c‐Myc, linked to an RI‐internalization sequence arising from the third α‐helix of Antennapedia (Int) was endowed with an antiproliferative and proapoptotic activity toward the cancer cell lines MCF‐7 and HCT‐116. The activity apparently was dependent upon the presence of the Myc motif. In this work, by ala‐scan mapping of the H1 portion of our molecules with D‐aa, we found two amino acids necessary for antiproliferative activity: D‐Lys in 4 and D‐Arg in 5 (numbers refer to L‐forms). In the natural hetero‐dimer, these two side chains project to the outside of the four α‐helix bundle. Moreover, we were able to obtain three peptides more active than the original lead. They strongly reduced cell proliferation and survival (RI‐Int‐VV‐H1‐E2A,S6A,F8A; RI‐Int‐VV‐H1‐S6A,F8A,R11A; RI‐Int‐VV‐H1‐S6A,F8A,Q13A): after 8 days at 10 µM total cell number was ∼1% of the number of cells initially seeded. In these more potent molecules, the ablated side chains project to the inside in the corresponding natural four α‐helix bundle. In the present work, we also investigated the behavior of our molecules at the biochemical level. Using both a circular dichroism (CD) and a fluorescence anisotropy approach, we noted that side chains projecting at the interior of the four α‐helix bundle are needed for inducing the partial unfolding of Myc‐H2, without an opening of the leucine zipper. Side chains projecting at the outside are not required for this biochemical effect. However, antiproliferative activity had the opposite requirements: side chains projecting at the outside of the bundle were essential, and, on the contrary, ablation of one side chain at a time projecting at the inside increased rather than decreased biological activity. We conclude that our active molecules probably interfere at the level of a protein–protein interaction between Myc‐Max and a third protein of the transcription complex. Finally, CD and nuclear magnetic resonance (NMR) data, plus dynamic simulations, suggest a prevalent random coil conformation of the H1 portion of our molecules, at least in diluted solutions. The introduction of a kink (substitution with proline in positions 5 or 7) led to an i
doi_str_mv 10.1096/fj.04-2369fje
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67552662</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67552662</sourcerecordid><originalsourceid>FETCH-LOGICAL-c342E-20168435c3e5e60efe94fb559933d30b7be131a0513b180d757f77144df52dd83</originalsourceid><addsrcrecordid>eNp9kM1O3DAUhS1EBdMpy24rr9gFruPYSbpr0UwBUbEYWFuJc63xyPlp7KHMjkdA6hvyJPVoIrFjc3-k7x6dewj5yuCCQSkvzeYCsiTlsjQbPCIzJjgkspBwTGZQlGkiJS9OyWfvNwDAgMkTcsqEzFksM_K8wj9b7DRSP6C2xmo64BBs07e2xRDXtneotw49td3a1jb0o6e9oRUdxj6g7d5e_k1TJAKOlQ6272gVaFgjXaOzz5RRh0_o9nf67eX1905_IZ9M5TyeTX1OHpeLh6vr5O7-183Vj7tE8yxdJGk0XGRcaI4CJaDBMjO1EGXJecOhzmtknFUgGK9ZAU0ucpPnLMsaI9KmKficnB90o8f4qQ-qtV6jc1WH_dYrmQuRSplGMDmAeuy9H9GoYbRtNe4UA7WPWpmNgkxNUUf-2yS8rVts3ukp2wh8PwB_rcPdx2pqufqZLm8h2-_L2wX_D_xlj6I</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67552662</pqid></control><display><type>article</type><title>Sequence specific peptidomimetic molecules inhibitors of a protein–protein interaction at the helix 1 level of c‐Myc</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Alma/SFX Local Collection</source><creator>Nieddu, E. ; Melchiori, A. ; Pescarolo, M. P. ; Bagnasco, L. ; Biasotti, B. ; Licheri, B. ; Malacarne, D. ; Tortolina, L. ; Castagnino, N. ; Pasa, S. ; Cimoli, G. ; Avignolo, C. ; Ponassi, R. ; Balbi, C. ; Patrone, E. ; D'Arrigo, C. ; Barboro, P. ; Vasile, F. ; Orecchia, P. ; Carnemolla, B. ; Damonte, G. ; Millo, E. ; Palomba, D. ; Fassina, G. ; Mazzei, M. ; Parodi, S.</creator><creatorcontrib>Nieddu, E. ; Melchiori, A. ; Pescarolo, M. P. ; Bagnasco, L. ; Biasotti, B. ; Licheri, B. ; Malacarne, D. ; Tortolina, L. ; Castagnino, N. ; Pasa, S. ; Cimoli, G. ; Avignolo, C. ; Ponassi, R. ; Balbi, C. ; Patrone, E. ; D'Arrigo, C. ; Barboro, P. ; Vasile, F. ; Orecchia, P. ; Carnemolla, B. ; Damonte, G. ; Millo, E. ; Palomba, D. ; Fassina, G. ; Mazzei, M. ; Parodi, S.</creatorcontrib><description>ABSTRACT Our work is focused in the broad area of strategies and efforts to inhibit protein–protein interactions. The possible strategies in this field are definitely much more varied than in the case of ATP‐pocket inhibitors. In our previous work (10), we reported that a retro‐inverso (RI) form of Helix1 (H1) of c‐Myc, linked to an RI‐internalization sequence arising from the third α‐helix of Antennapedia (Int) was endowed with an antiproliferative and proapoptotic activity toward the cancer cell lines MCF‐7 and HCT‐116. The activity apparently was dependent upon the presence of the Myc motif. In this work, by ala‐scan mapping of the H1 portion of our molecules with D‐aa, we found two amino acids necessary for antiproliferative activity: D‐Lys in 4 and D‐Arg in 5 (numbers refer to L‐forms). In the natural hetero‐dimer, these two side chains project to the outside of the four α‐helix bundle. Moreover, we were able to obtain three peptides more active than the original lead. They strongly reduced cell proliferation and survival (RI‐Int‐VV‐H1‐E2A,S6A,F8A; RI‐Int‐VV‐H1‐S6A,F8A,R11A; RI‐Int‐VV‐H1‐S6A,F8A,Q13A): after 8 days at 10 µM total cell number was ∼1% of the number of cells initially seeded. In these more potent molecules, the ablated side chains project to the inside in the corresponding natural four α‐helix bundle. In the present work, we also investigated the behavior of our molecules at the biochemical level. Using both a circular dichroism (CD) and a fluorescence anisotropy approach, we noted that side chains projecting at the interior of the four α‐helix bundle are needed for inducing the partial unfolding of Myc‐H2, without an opening of the leucine zipper. Side chains projecting at the outside are not required for this biochemical effect. However, antiproliferative activity had the opposite requirements: side chains projecting at the outside of the bundle were essential, and, on the contrary, ablation of one side chain at a time projecting at the inside increased rather than decreased biological activity. We conclude that our active molecules probably interfere at the level of a protein–protein interaction between Myc‐Max and a third protein of the transcription complex. Finally, CD and nuclear magnetic resonance (NMR) data, plus dynamic simulations, suggest a prevalent random coil conformation of the H1 portion of our molecules, at least in diluted solutions. The introduction of a kink (substitution with proline in positions 5 or 7) led to an important reduction of biological activity. We have also synthesized a longer peptido‐mimetic molecule (RI‐Int‐H1‐S6A,F8A‐loop‐H2) with the intent of obtaining a wider zone of interaction and a stronger interference at the level of the higher‐order structure (enhanceosome). RI‐Int‐H1‐S6A,F8A‐loop‐H2 was less active rather than more active in respect to RI‐Int‐VV‐H1‐S6A,F8A, apparently because it has a clear bent to form a β‐sheet (CD and NMR data).</description><identifier>ISSN: 0892-6638</identifier><identifier>EISSN: 1530-6860</identifier><identifier>DOI: 10.1096/fj.04-2369fje</identifier><identifier>PMID: 15671156</identifier><language>eng</language><publisher>United States</publisher><subject>Amino Acid Sequence ; Apoptosis ; Basic-Leucine Zipper Transcription Factors - chemistry ; Breast Neoplasms ; Cell Division - drug effects ; Cell Line, Tumor ; Circular Dichroism ; Colonic Neoplasms ; D-peptides ; Dimerization ; Drug Stability ; Fluorescein ; Fluorescence Polarization ; Fluorescent Dyes ; growth inhibition ; Hot Temperature ; Humans ; Magnetic Resonance Spectroscopy ; Molecular Sequence Data ; Peptides - chemical synthesis ; Peptides - chemistry ; Peptides - pharmacology ; Protein Denaturation ; Protein Structure, Secondary ; protein–protein contacts ; Proto-Oncogene Proteins c-myc - analysis ; Proto-Oncogene Proteins c-myc - chemistry ; Rhodamines - chemistry ; structural studies ; Structure-Activity Relationship</subject><ispartof>The FASEB journal, 2005-04, Vol.19 (6), p.1-26</ispartof><rights>FASEB</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c342E-20168435c3e5e60efe94fb559933d30b7be131a0513b180d757f77144df52dd83</citedby><cites>FETCH-LOGICAL-c342E-20168435c3e5e60efe94fb559933d30b7be131a0513b180d757f77144df52dd83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1096%2Ffj.04-2369fje$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1096%2Ffj.04-2369fje$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15671156$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nieddu, E.</creatorcontrib><creatorcontrib>Melchiori, A.</creatorcontrib><creatorcontrib>Pescarolo, M. P.</creatorcontrib><creatorcontrib>Bagnasco, L.</creatorcontrib><creatorcontrib>Biasotti, B.</creatorcontrib><creatorcontrib>Licheri, B.</creatorcontrib><creatorcontrib>Malacarne, D.</creatorcontrib><creatorcontrib>Tortolina, L.</creatorcontrib><creatorcontrib>Castagnino, N.</creatorcontrib><creatorcontrib>Pasa, S.</creatorcontrib><creatorcontrib>Cimoli, G.</creatorcontrib><creatorcontrib>Avignolo, C.</creatorcontrib><creatorcontrib>Ponassi, R.</creatorcontrib><creatorcontrib>Balbi, C.</creatorcontrib><creatorcontrib>Patrone, E.</creatorcontrib><creatorcontrib>D'Arrigo, C.</creatorcontrib><creatorcontrib>Barboro, P.</creatorcontrib><creatorcontrib>Vasile, F.</creatorcontrib><creatorcontrib>Orecchia, P.</creatorcontrib><creatorcontrib>Carnemolla, B.</creatorcontrib><creatorcontrib>Damonte, G.</creatorcontrib><creatorcontrib>Millo, E.</creatorcontrib><creatorcontrib>Palomba, D.</creatorcontrib><creatorcontrib>Fassina, G.</creatorcontrib><creatorcontrib>Mazzei, M.</creatorcontrib><creatorcontrib>Parodi, S.</creatorcontrib><title>Sequence specific peptidomimetic molecules inhibitors of a protein–protein interaction at the helix 1 level of c‐Myc</title><title>The FASEB journal</title><addtitle>FASEB J</addtitle><description>ABSTRACT Our work is focused in the broad area of strategies and efforts to inhibit protein–protein interactions. The possible strategies in this field are definitely much more varied than in the case of ATP‐pocket inhibitors. In our previous work (10), we reported that a retro‐inverso (RI) form of Helix1 (H1) of c‐Myc, linked to an RI‐internalization sequence arising from the third α‐helix of Antennapedia (Int) was endowed with an antiproliferative and proapoptotic activity toward the cancer cell lines MCF‐7 and HCT‐116. The activity apparently was dependent upon the presence of the Myc motif. In this work, by ala‐scan mapping of the H1 portion of our molecules with D‐aa, we found two amino acids necessary for antiproliferative activity: D‐Lys in 4 and D‐Arg in 5 (numbers refer to L‐forms). In the natural hetero‐dimer, these two side chains project to the outside of the four α‐helix bundle. Moreover, we were able to obtain three peptides more active than the original lead. They strongly reduced cell proliferation and survival (RI‐Int‐VV‐H1‐E2A,S6A,F8A; RI‐Int‐VV‐H1‐S6A,F8A,R11A; RI‐Int‐VV‐H1‐S6A,F8A,Q13A): after 8 days at 10 µM total cell number was ∼1% of the number of cells initially seeded. In these more potent molecules, the ablated side chains project to the inside in the corresponding natural four α‐helix bundle. In the present work, we also investigated the behavior of our molecules at the biochemical level. Using both a circular dichroism (CD) and a fluorescence anisotropy approach, we noted that side chains projecting at the interior of the four α‐helix bundle are needed for inducing the partial unfolding of Myc‐H2, without an opening of the leucine zipper. Side chains projecting at the outside are not required for this biochemical effect. However, antiproliferative activity had the opposite requirements: side chains projecting at the outside of the bundle were essential, and, on the contrary, ablation of one side chain at a time projecting at the inside increased rather than decreased biological activity. We conclude that our active molecules probably interfere at the level of a protein–protein interaction between Myc‐Max and a third protein of the transcription complex. Finally, CD and nuclear magnetic resonance (NMR) data, plus dynamic simulations, suggest a prevalent random coil conformation of the H1 portion of our molecules, at least in diluted solutions. The introduction of a kink (substitution with proline in positions 5 or 7) led to an important reduction of biological activity. We have also synthesized a longer peptido‐mimetic molecule (RI‐Int‐H1‐S6A,F8A‐loop‐H2) with the intent of obtaining a wider zone of interaction and a stronger interference at the level of the higher‐order structure (enhanceosome). RI‐Int‐H1‐S6A,F8A‐loop‐H2 was less active rather than more active in respect to RI‐Int‐VV‐H1‐S6A,F8A, apparently because it has a clear bent to form a β‐sheet (CD and NMR data).</description><subject>Amino Acid Sequence</subject><subject>Apoptosis</subject><subject>Basic-Leucine Zipper Transcription Factors - chemistry</subject><subject>Breast Neoplasms</subject><subject>Cell Division - drug effects</subject><subject>Cell Line, Tumor</subject><subject>Circular Dichroism</subject><subject>Colonic Neoplasms</subject><subject>D-peptides</subject><subject>Dimerization</subject><subject>Drug Stability</subject><subject>Fluorescein</subject><subject>Fluorescence Polarization</subject><subject>Fluorescent Dyes</subject><subject>growth inhibition</subject><subject>Hot Temperature</subject><subject>Humans</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Molecular Sequence Data</subject><subject>Peptides - chemical synthesis</subject><subject>Peptides - chemistry</subject><subject>Peptides - pharmacology</subject><subject>Protein Denaturation</subject><subject>Protein Structure, Secondary</subject><subject>protein–protein contacts</subject><subject>Proto-Oncogene Proteins c-myc - analysis</subject><subject>Proto-Oncogene Proteins c-myc - chemistry</subject><subject>Rhodamines - chemistry</subject><subject>structural studies</subject><subject>Structure-Activity Relationship</subject><issn>0892-6638</issn><issn>1530-6860</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1O3DAUhS1EBdMpy24rr9gFruPYSbpr0UwBUbEYWFuJc63xyPlp7KHMjkdA6hvyJPVoIrFjc3-k7x6dewj5yuCCQSkvzeYCsiTlsjQbPCIzJjgkspBwTGZQlGkiJS9OyWfvNwDAgMkTcsqEzFksM_K8wj9b7DRSP6C2xmo64BBs07e2xRDXtneotw49td3a1jb0o6e9oRUdxj6g7d5e_k1TJAKOlQ6272gVaFgjXaOzz5RRh0_o9nf67eX1905_IZ9M5TyeTX1OHpeLh6vr5O7-183Vj7tE8yxdJGk0XGRcaI4CJaDBMjO1EGXJecOhzmtknFUgGK9ZAU0ucpPnLMsaI9KmKficnB90o8f4qQ-qtV6jc1WH_dYrmQuRSplGMDmAeuy9H9GoYbRtNe4UA7WPWpmNgkxNUUf-2yS8rVts3ukp2wh8PwB_rcPdx2pqufqZLm8h2-_L2wX_D_xlj6I</recordid><startdate>200504</startdate><enddate>200504</enddate><creator>Nieddu, E.</creator><creator>Melchiori, A.</creator><creator>Pescarolo, M. P.</creator><creator>Bagnasco, L.</creator><creator>Biasotti, B.</creator><creator>Licheri, B.</creator><creator>Malacarne, D.</creator><creator>Tortolina, L.</creator><creator>Castagnino, N.</creator><creator>Pasa, S.</creator><creator>Cimoli, G.</creator><creator>Avignolo, C.</creator><creator>Ponassi, R.</creator><creator>Balbi, C.</creator><creator>Patrone, E.</creator><creator>D'Arrigo, C.</creator><creator>Barboro, P.</creator><creator>Vasile, F.</creator><creator>Orecchia, P.</creator><creator>Carnemolla, B.</creator><creator>Damonte, G.</creator><creator>Millo, E.</creator><creator>Palomba, D.</creator><creator>Fassina, G.</creator><creator>Mazzei, M.</creator><creator>Parodi, S.</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200504</creationdate><title>Sequence specific peptidomimetic molecules inhibitors of a protein–protein interaction at the helix 1 level of c‐Myc</title><author>Nieddu, E. ; Melchiori, A. ; Pescarolo, M. P. ; Bagnasco, L. ; Biasotti, B. ; Licheri, B. ; Malacarne, D. ; Tortolina, L. ; Castagnino, N. ; Pasa, S. ; Cimoli, G. ; Avignolo, C. ; Ponassi, R. ; Balbi, C. ; Patrone, E. ; D'Arrigo, C. ; Barboro, P. ; Vasile, F. ; Orecchia, P. ; Carnemolla, B. ; Damonte, G. ; Millo, E. ; Palomba, D. ; Fassina, G. ; Mazzei, M. ; Parodi, S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c342E-20168435c3e5e60efe94fb559933d30b7be131a0513b180d757f77144df52dd83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Amino Acid Sequence</topic><topic>Apoptosis</topic><topic>Basic-Leucine Zipper Transcription Factors - chemistry</topic><topic>Breast Neoplasms</topic><topic>Cell Division - drug effects</topic><topic>Cell Line, Tumor</topic><topic>Circular Dichroism</topic><topic>Colonic Neoplasms</topic><topic>D-peptides</topic><topic>Dimerization</topic><topic>Drug Stability</topic><topic>Fluorescein</topic><topic>Fluorescence Polarization</topic><topic>Fluorescent Dyes</topic><topic>growth inhibition</topic><topic>Hot Temperature</topic><topic>Humans</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Molecular Sequence Data</topic><topic>Peptides - chemical synthesis</topic><topic>Peptides - chemistry</topic><topic>Peptides - pharmacology</topic><topic>Protein Denaturation</topic><topic>Protein Structure, Secondary</topic><topic>protein–protein contacts</topic><topic>Proto-Oncogene Proteins c-myc - analysis</topic><topic>Proto-Oncogene Proteins c-myc - chemistry</topic><topic>Rhodamines - chemistry</topic><topic>structural studies</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nieddu, E.</creatorcontrib><creatorcontrib>Melchiori, A.</creatorcontrib><creatorcontrib>Pescarolo, M. P.</creatorcontrib><creatorcontrib>Bagnasco, L.</creatorcontrib><creatorcontrib>Biasotti, B.</creatorcontrib><creatorcontrib>Licheri, B.</creatorcontrib><creatorcontrib>Malacarne, D.</creatorcontrib><creatorcontrib>Tortolina, L.</creatorcontrib><creatorcontrib>Castagnino, N.</creatorcontrib><creatorcontrib>Pasa, S.</creatorcontrib><creatorcontrib>Cimoli, G.</creatorcontrib><creatorcontrib>Avignolo, C.</creatorcontrib><creatorcontrib>Ponassi, R.</creatorcontrib><creatorcontrib>Balbi, C.</creatorcontrib><creatorcontrib>Patrone, E.</creatorcontrib><creatorcontrib>D'Arrigo, C.</creatorcontrib><creatorcontrib>Barboro, P.</creatorcontrib><creatorcontrib>Vasile, F.</creatorcontrib><creatorcontrib>Orecchia, P.</creatorcontrib><creatorcontrib>Carnemolla, B.</creatorcontrib><creatorcontrib>Damonte, G.</creatorcontrib><creatorcontrib>Millo, E.</creatorcontrib><creatorcontrib>Palomba, D.</creatorcontrib><creatorcontrib>Fassina, G.</creatorcontrib><creatorcontrib>Mazzei, M.</creatorcontrib><creatorcontrib>Parodi, S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The FASEB journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nieddu, E.</au><au>Melchiori, A.</au><au>Pescarolo, M. P.</au><au>Bagnasco, L.</au><au>Biasotti, B.</au><au>Licheri, B.</au><au>Malacarne, D.</au><au>Tortolina, L.</au><au>Castagnino, N.</au><au>Pasa, S.</au><au>Cimoli, G.</au><au>Avignolo, C.</au><au>Ponassi, R.</au><au>Balbi, C.</au><au>Patrone, E.</au><au>D'Arrigo, C.</au><au>Barboro, P.</au><au>Vasile, F.</au><au>Orecchia, P.</au><au>Carnemolla, B.</au><au>Damonte, G.</au><au>Millo, E.</au><au>Palomba, D.</au><au>Fassina, G.</au><au>Mazzei, M.</au><au>Parodi, S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sequence specific peptidomimetic molecules inhibitors of a protein–protein interaction at the helix 1 level of c‐Myc</atitle><jtitle>The FASEB journal</jtitle><addtitle>FASEB J</addtitle><date>2005-04</date><risdate>2005</risdate><volume>19</volume><issue>6</issue><spage>1</spage><epage>26</epage><pages>1-26</pages><issn>0892-6638</issn><eissn>1530-6860</eissn><abstract>ABSTRACT Our work is focused in the broad area of strategies and efforts to inhibit protein–protein interactions. The possible strategies in this field are definitely much more varied than in the case of ATP‐pocket inhibitors. In our previous work (10), we reported that a retro‐inverso (RI) form of Helix1 (H1) of c‐Myc, linked to an RI‐internalization sequence arising from the third α‐helix of Antennapedia (Int) was endowed with an antiproliferative and proapoptotic activity toward the cancer cell lines MCF‐7 and HCT‐116. The activity apparently was dependent upon the presence of the Myc motif. In this work, by ala‐scan mapping of the H1 portion of our molecules with D‐aa, we found two amino acids necessary for antiproliferative activity: D‐Lys in 4 and D‐Arg in 5 (numbers refer to L‐forms). In the natural hetero‐dimer, these two side chains project to the outside of the four α‐helix bundle. Moreover, we were able to obtain three peptides more active than the original lead. They strongly reduced cell proliferation and survival (RI‐Int‐VV‐H1‐E2A,S6A,F8A; RI‐Int‐VV‐H1‐S6A,F8A,R11A; RI‐Int‐VV‐H1‐S6A,F8A,Q13A): after 8 days at 10 µM total cell number was ∼1% of the number of cells initially seeded. In these more potent molecules, the ablated side chains project to the inside in the corresponding natural four α‐helix bundle. In the present work, we also investigated the behavior of our molecules at the biochemical level. Using both a circular dichroism (CD) and a fluorescence anisotropy approach, we noted that side chains projecting at the interior of the four α‐helix bundle are needed for inducing the partial unfolding of Myc‐H2, without an opening of the leucine zipper. Side chains projecting at the outside are not required for this biochemical effect. However, antiproliferative activity had the opposite requirements: side chains projecting at the outside of the bundle were essential, and, on the contrary, ablation of one side chain at a time projecting at the inside increased rather than decreased biological activity. We conclude that our active molecules probably interfere at the level of a protein–protein interaction between Myc‐Max and a third protein of the transcription complex. Finally, CD and nuclear magnetic resonance (NMR) data, plus dynamic simulations, suggest a prevalent random coil conformation of the H1 portion of our molecules, at least in diluted solutions. The introduction of a kink (substitution with proline in positions 5 or 7) led to an important reduction of biological activity. We have also synthesized a longer peptido‐mimetic molecule (RI‐Int‐H1‐S6A,F8A‐loop‐H2) with the intent of obtaining a wider zone of interaction and a stronger interference at the level of the higher‐order structure (enhanceosome). RI‐Int‐H1‐S6A,F8A‐loop‐H2 was less active rather than more active in respect to RI‐Int‐VV‐H1‐S6A,F8A, apparently because it has a clear bent to form a β‐sheet (CD and NMR data).</abstract><cop>United States</cop><pmid>15671156</pmid><doi>10.1096/fj.04-2369fje</doi><tpages>26</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0892-6638
ispartof The FASEB journal, 2005-04, Vol.19 (6), p.1-26
issn 0892-6638
1530-6860
language eng
recordid cdi_proquest_miscellaneous_67552662
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Alma/SFX Local Collection
subjects Amino Acid Sequence
Apoptosis
Basic-Leucine Zipper Transcription Factors - chemistry
Breast Neoplasms
Cell Division - drug effects
Cell Line, Tumor
Circular Dichroism
Colonic Neoplasms
D-peptides
Dimerization
Drug Stability
Fluorescein
Fluorescence Polarization
Fluorescent Dyes
growth inhibition
Hot Temperature
Humans
Magnetic Resonance Spectroscopy
Molecular Sequence Data
Peptides - chemical synthesis
Peptides - chemistry
Peptides - pharmacology
Protein Denaturation
Protein Structure, Secondary
protein–protein contacts
Proto-Oncogene Proteins c-myc - analysis
Proto-Oncogene Proteins c-myc - chemistry
Rhodamines - chemistry
structural studies
Structure-Activity Relationship
title Sequence specific peptidomimetic molecules inhibitors of a protein–protein interaction at the helix 1 level of c‐Myc
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T12%3A56%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sequence%20specific%20peptidomimetic%20molecules%20inhibitors%20of%20a%20protein%E2%80%93protein%20interaction%20at%20the%20helix%201%20level%20of%20c%E2%80%90Myc&rft.jtitle=The%20FASEB%20journal&rft.au=Nieddu,%20E.&rft.date=2005-04&rft.volume=19&rft.issue=6&rft.spage=1&rft.epage=26&rft.pages=1-26&rft.issn=0892-6638&rft.eissn=1530-6860&rft_id=info:doi/10.1096/fj.04-2369fje&rft_dat=%3Cproquest_cross%3E67552662%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67552662&rft_id=info:pmid/15671156&rfr_iscdi=true